<!DOCTYPE html>
<html lang="" xml:lang="">
<head>

  <meta charset="utf-8" />
  <meta http-equiv="X-UA-Compatible" content="IE=edge" />
  <title>Chapter 3 Upper Extremity | Vascular Surgery Board Review</title>
  <meta name="description" content="This is an ebook version of board review content produced for Audible Bleeding: The Vascular Surgery Podcast" />
  <meta name="generator" content="bookdown 0.24 and GitBook 2.6.7" />

  <meta property="og:title" content="Chapter 3 Upper Extremity | Vascular Surgery Board Review" />
  <meta property="og:type" content="book" />
  <meta property="og:url" content="https://adam-mdmph.github.io/VS-Board-Review/" />
  
  <meta property="og:description" content="This is an ebook version of board review content produced for Audible Bleeding: The Vascular Surgery Podcast" />
  <meta name="github-repo" content="https://github.com/adam-mdmph/VS-Board-Review" />

  <meta name="twitter:card" content="summary" />
  <meta name="twitter:title" content="Chapter 3 Upper Extremity | Vascular Surgery Board Review" />
  
  <meta name="twitter:description" content="This is an ebook version of board review content produced for Audible Bleeding: The Vascular Surgery Podcast" />
  

<meta name="author" content="Audible Bleeding" />


<meta name="date" content="2022-01-30" />

  <meta name="viewport" content="width=device-width, initial-scale=1" />
  <meta name="apple-mobile-web-app-capable" content="yes" />
  <meta name="apple-mobile-web-app-status-bar-style" content="black" />
  
  
<link rel="prev" href="cerebrovascular.html"/>
<link rel="next" href="thoracic-outlet-syndrome.html"/>
<script src="libs/header-attrs-2.11/header-attrs.js"></script>
<script src="libs/jquery-3.6.0/jquery-3.6.0.min.js"></script>
<script src="https://cdn.jsdelivr.net/npm/fuse.js@6.4.6/dist/fuse.min.js"></script>
<link href="libs/gitbook-2.6.7/css/style.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-table.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-bookdown.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-highlight.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-search.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-fontsettings.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-clipboard.css" rel="stylesheet" />








<link href="libs/anchor-sections-1.0.1/anchor-sections.css" rel="stylesheet" />
<script src="libs/anchor-sections-1.0.1/anchor-sections.js"></script>



<style type="text/css">
/* Used with Pandoc 2.11+ new --citeproc when CSL is used */
div.csl-bib-body { }
div.csl-entry {
  clear: both;
}
.hanging div.csl-entry {
  margin-left:2em;
  text-indent:-2em;
}
div.csl-left-margin {
  min-width:2em;
  float:left;
}
div.csl-right-inline {
  margin-left:2em;
  padding-left:1em;
}
div.csl-indent {
  margin-left: 2em;
}
</style>

<link rel="stylesheet" href="style.css" type="text/css" />
</head>

<body>



  <div class="book without-animation with-summary font-size-2 font-family-1" data-basepath=".">

    <div class="book-summary">
      <nav role="navigation">

<ul class="summary">
<li><a href="./">VS Board Review</a></li>

<li class="divider"></li>
<li class="chapter" data-level="1" data-path="index.html"><a href="index.html"><i class="fa fa-check"></i><b>1</b> About</a>
<ul>
<li class="chapter" data-level="1.1" data-path="index.html"><a href="index.html#usage"><i class="fa fa-check"></i><b>1.1</b> Usage</a></li>
<li class="chapter" data-level="1.2" data-path="index.html"><a href="index.html#comments-questions-or-contributions"><i class="fa fa-check"></i><b>1.2</b> Comments, Questions or Contributions</a></li>
</ul></li>
<li class="chapter" data-level="2" data-path="cerebrovascular.html"><a href="cerebrovascular.html"><i class="fa fa-check"></i><b>2</b> Cerebrovascular</a>
<ul>
<li class="chapter" data-level="2.1" data-path="cerebrovascular.html"><a href="cerebrovascular.html#available-guidelines"><i class="fa fa-check"></i><b>2.1</b> Available Guidelines</a></li>
<li class="chapter" data-level="2.2" data-path="cerebrovascular.html"><a href="cerebrovascular.html#presentation-and-diagnosis"><i class="fa fa-check"></i><b>2.2</b> Presentation and Diagnosis</a></li>
<li class="chapter" data-level="2.3" data-path="cerebrovascular.html"><a href="cerebrovascular.html#management"><i class="fa fa-check"></i><b>2.3</b> Management</a>
<ul>
<li class="chapter" data-level="2.3.1" data-path="cerebrovascular.html"><a href="cerebrovascular.html#optimal-medical-therapy"><i class="fa fa-check"></i><b>2.3.1</b> <strong>Optimal medical therapy</strong></a></li>
<li class="chapter" data-level="2.3.2" data-path="cerebrovascular.html"><a href="cerebrovascular.html#carotid-endarterectomy"><i class="fa fa-check"></i><b>2.3.2</b> <strong>Carotid endarterectomy</strong></a></li>
<li class="chapter" data-level="2.3.3" data-path="cerebrovascular.html"><a href="cerebrovascular.html#carotid-artery-stenting"><i class="fa fa-check"></i><b>2.3.3</b> Carotid Artery Stenting</a></li>
<li class="chapter" data-level="2.3.4" data-path="cerebrovascular.html"><a href="cerebrovascular.html#management-of-uncommon-disease-presentations"><i class="fa fa-check"></i><b>2.3.4</b> Management of uncommon disease presentations</a></li>
</ul></li>
<li class="chapter" data-level="2.4" data-path="cerebrovascular.html"><a href="cerebrovascular.html#prospective-trials---must-reads"><i class="fa fa-check"></i><b>2.4</b> Prospective Trials - MUST READS</a></li>
</ul></li>
<li class="chapter" data-level="3" data-path="upper-extremity.html"><a href="upper-extremity.html"><i class="fa fa-check"></i><b>3</b> Upper Extremity</a>
<ul>
<li class="chapter" data-level="3.1" data-path="upper-extremity.html"><a href="upper-extremity.html#anatomy-exposure-of-vessels"><i class="fa fa-check"></i><b>3.1</b> Anatomy/ Exposure of Vessels</a></li>
<li class="chapter" data-level="3.2" data-path="upper-extremity.html"><a href="upper-extremity.html#epidemiology-etiology-and-diagnostic-evaluation"><i class="fa fa-check"></i><b>3.2</b> Epidemiology, etiology, and diagnostic evaluation</a></li>
<li class="chapter" data-level="3.3" data-path="upper-extremity.html"><a href="upper-extremity.html#vaso-occlusive-disease"><i class="fa fa-check"></i><b>3.3</b> Vaso-occlusive disease</a></li>
<li class="chapter" data-level="3.4" data-path="upper-extremity.html"><a href="upper-extremity.html#vasospastic-disorders"><i class="fa fa-check"></i><b>3.4</b> Vasospastic Disorders</a>
<ul>
<li class="chapter" data-level="3.4.1" data-path="upper-extremity.html"><a href="upper-extremity.html#ergotism"><i class="fa fa-check"></i><b>3.4.1</b> <strong>Ergotism</strong></a></li>
<li class="chapter" data-level="3.4.2" data-path="upper-extremity.html"><a href="upper-extremity.html#buergers-disease"><i class="fa fa-check"></i><b>3.4.2</b> <strong>Buerger’s Disease</strong></a></li>
<li class="chapter" data-level="3.4.3" data-path="upper-extremity.html"><a href="upper-extremity.html#large-artery-vasculitis"><i class="fa fa-check"></i><b>3.4.3</b> <strong>Large Artery Vasculitis</strong></a></li>
</ul></li>
<li class="chapter" data-level="3.5" data-path="upper-extremity.html"><a href="upper-extremity.html#aneurysmal-disease"><i class="fa fa-check"></i><b>3.5</b> Aneurysmal Disease</a></li>
<li class="chapter" data-level="3.6" data-path="upper-extremity.html"><a href="upper-extremity.html#occupational-vascular-disease"><i class="fa fa-check"></i><b>3.6</b> Occupational Vascular Disease</a>
<ul>
<li class="chapter" data-level="3.6.1" data-path="upper-extremity.html"><a href="upper-extremity.html#hand-arm-vibration-syndrome"><i class="fa fa-check"></i><b>3.6.1</b> Hand-Arm Vibration Syndrome </a></li>
<li class="chapter" data-level="3.6.2" data-path="upper-extremity.html"><a href="upper-extremity.html#hypothenar-hammer-syndrome"><i class="fa fa-check"></i><b>3.6.2</b> Hypothenar hammer syndrome</a></li>
<li class="chapter" data-level="3.6.3" data-path="upper-extremity.html"><a href="upper-extremity.html#environmental-exposures"><i class="fa fa-check"></i><b>3.6.3</b> Environmental Exposures</a></li>
<li class="chapter" data-level="3.6.4" data-path="upper-extremity.html"><a href="upper-extremity.html#sports-medicine"><i class="fa fa-check"></i><b>3.6.4</b> Sports Medicine</a></li>
</ul></li>
<li class="chapter" data-level="3.7" data-path="upper-extremity.html"><a href="upper-extremity.html#compression-syndromes"><i class="fa fa-check"></i><b>3.7</b> Compression Syndromes</a>
<ul>
<li class="chapter" data-level="3.7.1" data-path="upper-extremity.html"><a href="upper-extremity.html#quadrilateral-space-syndrome"><i class="fa fa-check"></i><b>3.7.1</b> Quadrilateral space syndrome</a></li>
<li class="chapter" data-level="3.7.2" data-path="upper-extremity.html"><a href="upper-extremity.html#humeral-head-compression-of-axillary-artery"><i class="fa fa-check"></i><b>3.7.2</b> Humeral head compression of axillary artery</a></li>
<li class="chapter" data-level="3.7.3" data-path="upper-extremity.html"><a href="upper-extremity.html#thoracic-outlet-compression"><i class="fa fa-check"></i><b>3.7.3</b> Thoracic Outlet Compression</a></li>
</ul></li>
<li class="chapter" data-level="3.8" data-path="upper-extremity.html"><a href="upper-extremity.html#vascular-trauma-upper-extremity"><i class="fa fa-check"></i><b>3.8</b> Vascular Trauma-Upper Extremity</a></li>
<li class="chapter" data-level="3.9" data-path="upper-extremity.html"><a href="upper-extremity.html#operationsprocedures"><i class="fa fa-check"></i><b>3.9</b> Operations/Procedures</a></li>
</ul></li>
<li class="chapter" data-level="4" data-path="thoracic-outlet-syndrome.html"><a href="thoracic-outlet-syndrome.html"><i class="fa fa-check"></i><b>4</b> Thoracic Outlet Syndrome</a>
<ul>
<li class="chapter" data-level="4.1" data-path="thoracic-outlet-syndrome.html"><a href="thoracic-outlet-syndrome.html#anatomy"><i class="fa fa-check"></i><b>4.1</b> Anatomy</a></li>
<li class="chapter" data-level="4.2" data-path="thoracic-outlet-syndrome.html"><a href="thoracic-outlet-syndrome.html#diagnosis-and-evaluation"><i class="fa fa-check"></i><b>4.2</b> Diagnosis and Evaluation</a>
<ul>
<li class="chapter" data-level="4.2.1" data-path="thoracic-outlet-syndrome.html"><a href="thoracic-outlet-syndrome.html#patient-history"><i class="fa fa-check"></i><b>4.2.1</b> Patient History</a></li>
<li class="chapter" data-level="4.2.2" data-path="thoracic-outlet-syndrome.html"><a href="thoracic-outlet-syndrome.html#clinical-examination"><i class="fa fa-check"></i><b>4.2.2</b> Clinical Examination</a></li>
<li class="chapter" data-level="4.2.3" data-path="thoracic-outlet-syndrome.html"><a href="thoracic-outlet-syndrome.html#non-invasive-imaging-or-vascular-lab-studies"><i class="fa fa-check"></i><b>4.2.3</b> Non-invasive imaging or vascular lab studies</a></li>
</ul></li>
<li class="chapter" data-level="4.3" data-path="thoracic-outlet-syndrome.html"><a href="thoracic-outlet-syndrome.html#rib-resection-approaches"><i class="fa fa-check"></i><b>4.3</b> Rib Resection approaches</a></li>
<li class="chapter" data-level="4.4" data-path="thoracic-outlet-syndrome.html"><a href="thoracic-outlet-syndrome.html#vtos"><i class="fa fa-check"></i><b>4.4</b> vTOS</a>
<ul>
<li class="chapter" data-level="4.4.1" data-path="thoracic-outlet-syndrome.html"><a href="thoracic-outlet-syndrome.html#presentation"><i class="fa fa-check"></i><b>4.4.1</b> Presentation</a></li>
<li class="chapter" data-level="4.4.2" data-path="thoracic-outlet-syndrome.html"><a href="thoracic-outlet-syndrome.html#history"><i class="fa fa-check"></i><b>4.4.2</b> History</a></li>
<li class="chapter" data-level="4.4.3" data-path="thoracic-outlet-syndrome.html"><a href="thoracic-outlet-syndrome.html#goals-of-therapy-for-vtos"><i class="fa fa-check"></i><b>4.4.3</b> Goals of therapy for vTOS</a></li>
<li class="chapter" data-level="4.4.4" data-path="thoracic-outlet-syndrome.html"><a href="thoracic-outlet-syndrome.html#initial-management-strategy"><i class="fa fa-check"></i><b>4.4.4</b> Initial management strategy</a></li>
<li class="chapter" data-level="4.4.5" data-path="thoracic-outlet-syndrome.html"><a href="thoracic-outlet-syndrome.html#controversy-around-vtos"><i class="fa fa-check"></i><b>4.4.5</b> Controversy around vTOS</a></li>
<li class="chapter" data-level="4.4.6" data-path="thoracic-outlet-syndrome.html"><a href="thoracic-outlet-syndrome.html#landmark-papers-regarding-vtos-and-what-are-the-take-home-messages"><i class="fa fa-check"></i><b>4.4.6</b> Landmark papers regarding vTOS and what are the take home messages</a></li>
</ul></li>
<li class="chapter" data-level="4.5" data-path="thoracic-outlet-syndrome.html"><a href="thoracic-outlet-syndrome.html#atos"><i class="fa fa-check"></i><b>4.5</b> aTOS</a>
<ul>
<li class="chapter" data-level="4.5.1" data-path="thoracic-outlet-syndrome.html"><a href="thoracic-outlet-syndrome.html#presentation-1"><i class="fa fa-check"></i><b>4.5.1</b> Presentation</a></li>
<li class="chapter" data-level="4.5.2" data-path="thoracic-outlet-syndrome.html"><a href="thoracic-outlet-syndrome.html#important-differentials-for-atos"><i class="fa fa-check"></i><b>4.5.2</b> Important differentials for aTOS</a></li>
<li class="chapter" data-level="4.5.3" data-path="thoracic-outlet-syndrome.html"><a href="thoracic-outlet-syndrome.html#most-common-causes-of-atos---the-different-anatomical-abnormalities-causing-atos-incidence"><i class="fa fa-check"></i><b>4.5.3</b> Most common causes of aTOS - The different Anatomical Abnormalities causing aTOS (incidence %)</a></li>
<li class="chapter" data-level="4.5.4" data-path="thoracic-outlet-syndrome.html"><a href="thoracic-outlet-syndrome.html#scher-staging-of-atos"><i class="fa fa-check"></i><b>4.5.4</b> Scher Staging of aTOS</a></li>
<li class="chapter" data-level="4.5.5" data-path="thoracic-outlet-syndrome.html"><a href="thoracic-outlet-syndrome.html#management-considerations-with-atos"><i class="fa fa-check"></i><b>4.5.5</b> Management considerations with aTOS</a></li>
</ul></li>
<li class="chapter" data-level="4.6" data-path="thoracic-outlet-syndrome.html"><a href="thoracic-outlet-syndrome.html#ntos"><i class="fa fa-check"></i><b>4.6</b> nTOS</a>
<ul>
<li class="chapter" data-level="4.6.1" data-path="thoracic-outlet-syndrome.html"><a href="thoracic-outlet-syndrome.html#demographics"><i class="fa fa-check"></i><b>4.6.1</b> Demographics</a></li>
<li class="chapter" data-level="4.6.2" data-path="thoracic-outlet-syndrome.html"><a href="thoracic-outlet-syndrome.html#presentation-of-ntos"><i class="fa fa-check"></i><b>4.6.2</b> Presentation of nTOS</a></li>
<li class="chapter" data-level="4.6.3" data-path="thoracic-outlet-syndrome.html"><a href="thoracic-outlet-syndrome.html#the-role-of-the-vascular-surgeon-with-ntos"><i class="fa fa-check"></i><b>4.6.3</b> The role of the Vascular Surgeon with nTOS</a></li>
</ul></li>
</ul></li>
<li class="chapter" data-level="5" data-path="abdominaliliacperipheral-aneurysms.html"><a href="abdominaliliacperipheral-aneurysms.html"><i class="fa fa-check"></i><b>5</b> Abdominal/Iliac/Peripheral Aneurysms</a>
<ul>
<li class="chapter" data-level="5.1" data-path="abdominaliliacperipheral-aneurysms.html"><a href="abdominaliliacperipheral-aneurysms.html#section"><i class="fa fa-check"></i><b>5.1</b> </a></li>
</ul></li>
<li class="chapter" data-level="6" data-path="lower-extremity-occlusive-disease.html"><a href="lower-extremity-occlusive-disease.html"><i class="fa fa-check"></i><b>6</b> Lower Extremity Occlusive Disease</a>
<ul>
<li class="chapter" data-level="6.1" data-path="lower-extremity-occlusive-disease.html"><a href="lower-extremity-occlusive-disease.html#section-1"><i class="fa fa-check"></i><b>6.1</b> </a></li>
</ul></li>
<li class="chapter" data-level="7" data-path="mesenteric-disease.html"><a href="mesenteric-disease.html"><i class="fa fa-check"></i><b>7</b> Mesenteric Disease</a>
<ul>
<li class="chapter" data-level="7.1" data-path="mesenteric-disease.html"><a href="mesenteric-disease.html#section-2"><i class="fa fa-check"></i><b>7.1</b> </a></li>
</ul></li>
<li class="chapter" data-level="8" data-path="renal.html"><a href="renal.html"><i class="fa fa-check"></i><b>8</b> Renal</a>
<ul>
<li class="chapter" data-level="8.1" data-path="renal.html"><a href="renal.html#section-3"><i class="fa fa-check"></i><b>8.1</b> </a></li>
</ul></li>
<li class="chapter" data-level="9" data-path="thoracic-aorta.html"><a href="thoracic-aorta.html"><i class="fa fa-check"></i><b>9</b> Thoracic Aorta</a>
<ul>
<li class="chapter" data-level="9.1" data-path="thoracic-aorta.html"><a href="thoracic-aorta.html#section-4"><i class="fa fa-check"></i><b>9.1</b> </a></li>
</ul></li>
<li class="chapter" data-level="10" data-path="venous-disease.html"><a href="venous-disease.html"><i class="fa fa-check"></i><b>10</b> Venous Disease</a>
<ul>
<li class="chapter" data-level="10.1" data-path="venous-disease.html"><a href="venous-disease.html#section-5"><i class="fa fa-check"></i><b>10.1</b> </a></li>
</ul></li>
<li class="chapter" data-level="11" data-path="vascular-trauma.html"><a href="vascular-trauma.html"><i class="fa fa-check"></i><b>11</b> Vascular Trauma</a>
<ul>
<li class="chapter" data-level="11.1" data-path="vascular-trauma.html"><a href="vascular-trauma.html#section-6"><i class="fa fa-check"></i><b>11.1</b> </a></li>
</ul></li>
<li class="chapter" data-level="12" data-path="angioaccess.html"><a href="angioaccess.html"><i class="fa fa-check"></i><b>12</b> Angioaccess</a>
<ul>
<li class="chapter" data-level="12.1" data-path="angioaccess.html"><a href="angioaccess.html#section-7"><i class="fa fa-check"></i><b>12.1</b> </a></li>
</ul></li>
<li class="chapter" data-level="13" data-path="complications.html"><a href="complications.html"><i class="fa fa-check"></i><b>13</b> Complications</a>
<ul>
<li class="chapter" data-level="13.1" data-path="complications.html"><a href="complications.html#section-8"><i class="fa fa-check"></i><b>13.1</b> </a></li>
</ul></li>
<li class="chapter" data-level="14" data-path="amputations.html"><a href="amputations.html"><i class="fa fa-check"></i><b>14</b> Amputations</a>
<ul>
<li class="chapter" data-level="14.1" data-path="amputations.html"><a href="amputations.html#section-9"><i class="fa fa-check"></i><b>14.1</b> </a></li>
</ul></li>
<li class="chapter" data-level="15" data-path="vascular-lab.html"><a href="vascular-lab.html"><i class="fa fa-check"></i><b>15</b> Vascular Lab</a>
<ul>
<li class="chapter" data-level="15.1" data-path="vascular-lab.html"><a href="vascular-lab.html#section-10"><i class="fa fa-check"></i><b>15.1</b> </a></li>
</ul></li>
<li class="chapter" data-level="16" data-path="vascular-medicine.html"><a href="vascular-medicine.html"><i class="fa fa-check"></i><b>16</b> Vascular Medicine</a>
<ul>
<li class="chapter" data-level="16.1" data-path="vascular-medicine.html"><a href="vascular-medicine.html#section-11"><i class="fa fa-check"></i><b>16.1</b> </a></li>
</ul></li>
<li class="chapter" data-level="17" data-path="endovascular.html"><a href="endovascular.html"><i class="fa fa-check"></i><b>17</b> Endovascular</a>
<ul>
<li class="chapter" data-level="17.1" data-path="endovascular.html"><a href="endovascular.html#section-12"><i class="fa fa-check"></i><b>17.1</b> </a></li>
</ul></li>
<li class="chapter" data-level="18" data-path="applied-science.html"><a href="applied-science.html"><i class="fa fa-check"></i><b>18</b> Applied Science</a>
<ul>
<li class="chapter" data-level="18.1" data-path="applied-science.html"><a href="applied-science.html#section-13"><i class="fa fa-check"></i><b>18.1</b> </a></li>
</ul></li>
<li class="chapter" data-level="" data-path="references.html"><a href="references.html"><i class="fa fa-check"></i>References</a></li>
<li class="divider"></li>
<li><a href="https://github.com/rstudio/bookdown" target="blank">Published with bookdown</a></li>

</ul>

      </nav>
    </div>

    <div class="book-body">
      <div class="body-inner">
        <div class="book-header" role="navigation">
          <h1>
            <i class="fa fa-circle-o-notch fa-spin"></i><a href="./">Vascular Surgery Board Review</a>
          </h1>
        </div>

        <div class="page-wrapper" tabindex="-1" role="main">
          <div class="page-inner">

            <section class="normal" id="section-">
<div id="upper-extremity" class="section level1" number="3">
<h1><span class="header-section-number">Chapter 3</span> Upper Extremity</h1>
<p><strong>21 Jan 2021</strong>: <em>Kush Sharma, MD and Ashraf Mansour, MD</em></p>
<p><audio controls> <source src='https://traffic.libsyn.com/audiblebleeding/VSITE_Upper_Extremity_post_auphonic.mp3' type='audio/mpeg'> Your browser does not support the audio tag;  for browser support, please see:  https://www.w3schools.com/tags/tag_audio.asp </audio></p>
<div id="anatomy-exposure-of-vessels" class="section level2" number="3.1">
<h2><span class="header-section-number">3.1</span> Anatomy/ Exposure of Vessels</h2>
<p><strong>What are the zones of the upper extremity?</strong><span class="citation"><sup><a href="#ref-illig57UpperExtremity" role="doc-biblioref">21</a></sup></span></p>
<p>Division of the upper extremity into three zones:</p>
<ol style="list-style-type: decimal">
<li><p>Intrathoracic zone including aortic arch, innominate artery,
subclavian artery bilaterally, innominate veins, and SVC</p></li>
<li><p>Thoracic outlet (base of neck to the axilla including the
subclavian, proximal vertebral, proximal axillary arteries/veins)</p></li>
<li><p>Axilla to fingers (the arm)</p></li>
</ol>
<p><strong>What are some common exposures for major upper extremity arteries?</strong></p>
<p>Right Subclavian Artery: Medial sternotomy (proximal) or right
supraclavicular area (mid/distal)</p>
<p>Left Subclavian Artery: Anterolateral thoracotomy in emergent setting
for proximal left subclavian artery control. When third space
sternotomy, supraclavicular incision with thoracotomy “trap door”
exposure</p>
<p>Supraclavicular incision: After division of the platysma and clavicular
head of the SCM, fat pat of varying thickness contains the omohyoid
muscle. This should be divided and placed superiorly/laterally. At this
point, the anterior scalene muscle is exposed medially with phrenic
nerve running in lateral to medial direction. Division of anterior
scalene for carotid/subclavian bypass should be performed as close to
the first rib as possible. After this is performed, the subclavian
artery is exposed.</p>
<p>Axillary Artery: Infraclavicular exposure below middle 1/3rd of
clavicle. Pec major split and pec minor freed at lateral wound. Axillary
vein followed by deep and superior to get to artery</p>
<p>Anatomically bound by the first rib proximally and the lateral edge of
the teres major muscle distally. For exposure of the first part of the
axillary artery, the ipsilateral arm is abducted approximately 90
degrees and horizontal skin incision 2 cm below the middle third of the
clavicle. Underlying pec major is split by bluntly separating the fibers
and followed by exposing the tough clavipectoral fascia. At the lateral
wound, the pec minor can be freed and laterally retracted. The axillary
vein is first structure encountered in the sheath and the artery lies
just superior and deep to the vein. Make sure to avoid nerves of
brachial plexus that lie deep to first part of axillary artery and are
at risk for injury during blind placement of occluding arterial clamps.<span class="citation"><sup><a href="#ref-garygwindAnatomicExposuresVascular2013" role="doc-biblioref">22</a></sup></span></p>
<p><strong>What steps are involved for brachial artery exposure?</strong></p>
<p>Brachial artery: incision between biceps/triceps on medial arm (avoid
basilic vein damage in subcutaneous and deep to the fasia at medial
biceps. Median nerve seen and retracted. Two brachial vein are paired
adjacent to artery.</p>
<p>Superficial location makes it vulnerable to injury and accounts for most
vascular injuries of upper extremities. Brachial artery exposure
involves a 5-8 cm longitudinal incision in the groove between the
biceps/triceps muscles on the medial aspect of the arm. In the lower
half of the arm, take care to avoid basilic vein damage in the
subcutaneous tissue. Neurovascular bundle exposed by incising the deep
fascia at the medial border of the biceps muscle, which is retracted
anteriorly. After retracting basilic vein into posterior wound ,brachial
sheath is opened and median nerve is most superficial structure and
retracted. The artery lies deep to the nerve and surrounded by two
brachial veins. Posteriorly, is the presence of the ulnar nerve.</p>
<p>Brachial Artery bifurcates at the radial tuberosity into radial/ulnar
branches. After the bifurcation and immediately after its origin, the
ulnar artery gives off a short common interosseous branch, which
bifurcates at the hiatus in the proximal interosseous membrane. Exposure
of brachial artery in the antecubital fossa requires a transverse skin
incision 1 cm distal to the midpoint of the antecubital crease. After
deepening, avoid injury to subcutaneous veins and mobilize the basilic
vein medially. Medial antebrachial cutaneous nerve should be protected.
Divide the bicipital aponeurosis and after division, exposure of the
brachial artery is present, which is flanked by two deep veins and
crossing branches. Isolation of brachial artery requires ligation and
division of these crossing vein branches.</p>
<p>Radial artery at the wrist with 2-3 cm longitudinal incision generally
between radial artery and cephalic vein. Radial artery was exposed by
incising the antebrachial fascia just medial to the radius. Two veins
accompany the artery and should be dissected away during arterial
isolation. The superficial radial nerve and its medial/lateral branches
course between the cephalic vein and radial artery in the area.</p>
<p>Exposure of the ulnar artery is by coursing beneath the superficial
flexor muscles in the proximal forearm, emerging near the ulnar border
at the point midway between the elbow and the wrist. In the distal
forearm, the ulnar artery course just beneath the antebrachial fascia
and is easily exposed through a longitudinal incision placed radial to
the flexor carbi ulnaris. The palmar branch of the ulnar nerve courses
the superficial to the antebrachial fascia and should be preserved
during arterial exposure</p>
<p><strong>What common aberrant upper extremity/arch anatomy is important to be
aware of?</strong></p>
<ul>
<li><p>Bovine arch with left common carotid/left subclavian have common
origin</p></li>
<li><p>Vertebral artery directly off the aortic arch</p></li>
<li><p>Aberrant right subclavian where innominate becomes right CCA and
right subclavian distal to last branch on left side passing behind
esophagus to supply the right arm</p></li>
</ul>
</div>
<div id="epidemiology-etiology-and-diagnostic-evaluation" class="section level2" number="3.2">
<h2><span class="header-section-number">3.2</span> Epidemiology, etiology, and diagnostic evaluation</h2>
<p><strong>How does evaluation of upper extremity ischemia differentiate from
lower extremity ischemia?</strong><span class="citation"><sup><a href="#ref-shuja117UpperExtremity" role="doc-biblioref">23</a></sup></span></p>
<ul>
<li><p>Upper extremity ischemia &lt;5% of patients with limb ischemia and in
contrast to lower extremity, atherosclerosis is not a major
contributor to upper extremity ischemia</p></li>
<li><p>Vast majority of cases caused by autoimmune/connective tissue
disorders</p></li>
</ul>
<p><strong>How can upper extremity disease be classified?</strong></p>
<p>Anatomic Location:</p>
<ul>
<li>Large vs. Small Vessel</li>
</ul>
<p>Disease Process:</p>
<ul>
<li>Vasospastic or occlusive. Vasospastic disease is more responsive to
pharmacologic management while occlusive requiring
endovascular/surgical management.</li>
</ul>
<p><strong>How should patients be evaluated who have concern for upper extremity
disease?</strong></p>
<p>Diagnostic Evaluation</p>
<ol style="list-style-type: decimal">
<li><p>Detailed H+P evaluation (pulse palpation, auscultation at
supraclavicular/infraclavicular fossa may reaveal a bruit concerning
for subclavian artery stenosis, upper extremity neurovascular/skin
exam)</p></li>
<li><p>Brachial/forearm blood pressures and if suspected claudication,
measured at rest and 2-5 minutes after exercise. Look for a gradient
of &gt;20 mmHg is considered significant</p></li>
<li><p>Some or all of 6 P’s of acute limb ischemia with symptoms occurring
within 14 days are deemed acute</p></li>
<li><p>Doppler insonation of radial, ulnar, palmar, and digital arteries</p></li>
<li><p>Vascular Lab Evaluation</p>
<ol style="list-style-type: decimal">
<li><p>Segmental Pressure Measurements</p></li>
<li><p>Duplex Ultrasound (look for large vessel occlusive disease)</p></li>
</ol></li>
<li><p>Other Imaging</p>
<ol style="list-style-type: decimal">
<li>CTA/MRA</li>
</ol></li>
<li><p>Clinical Lab tests</p>
<ol style="list-style-type: decimal">
<li><p>Inflammatory disorders-CBC, ESR, ANA, RF</p></li>
<li><p>Hypercoagulable screening</p></li>
</ol></li>
</ol>
</div>
<div id="vaso-occlusive-disease" class="section level2" number="3.3">
<h2><span class="header-section-number">3.3</span> Vaso-occlusive disease</h2>
<p><strong>What are causes and symptoms associated with subclavian/axillary
occlusive disease?</strong><span class="citation"><sup><a href="#ref-jacklcronenwettVascularDecisionMaking2020" role="doc-biblioref">24</a></sup></span></p>
<ul>
<li><p>Etiology: Atherosclerosis is the most common cause of
subclavian/axillary occlusive disease. Left SCA &gt; Right involvement.
Less common causes include Takayasu disease, giant cell arteritis,
or arterial TOS</p></li>
<li><p>Symptoms: Upper extremity arm/hand ischemia or neurologic symptoms
due to subclavian-vertebral steal. Because significant collaterals,
minimal pain on exertion even with subclavian occlusion</p></li>
</ul>
<p><strong>What are causes and symptoms associated with brachial/forearm
occlusive disease?</strong></p>
<ul>
<li><p>Etiology: MCC of brachial artery occlusion is cardiac origin
embolus. Atherosclerosis RARELY affects the brachial artery. Distal
axillary/proximal brachial stenosis can be from repetitive trauma
from crutch use. </p></li>
<li><p>Forearm occlusive disease can be seen in advanced ESRD/DM where
calcific atherosclerosis of radial/ulnar arteries is present. Less
common causes include Beurger disease or Raynaud Phenomenon </p></li>
</ul>
<p><strong>How/when is upper extremity occlusive disease treated?</strong></p>
<ul>
<li><p>SCA Occlusive Disease</p>
<ul>
<li><p>Endovascular: treated with stenting if they are short segment
and not close to the vertebral artery origin. Balloon expandable
stents favorable for ostial lesions and access can be via the
femoral or ipsilateral brachial artery </p></li>
<li><p>Surgery:</p>
<ul>
<li><p>Bypass from aortic arch through median sternotomy </p></li>
<li><p>Ipsilateral CCA to subclavian artery (bypass or
transposition) </p></li>
<li><p>Contralateral CCA (anterior or retropharyngeal)</p></li>
</ul></li>
</ul></li>
<li><p>Brachial/forearm Occlusive disease </p>
<ul>
<li><p>Endovascular: PTA evidence is anecdotal with stents for lesions
unresponsive to PTA or dissection following angioplasty </p></li>
<li><p>Surgery: </p>
<ul>
<li>GSV vein bypass remains standard for revascularization with
bypasses to superficial or deep palmar arch have good
patency rates. Tunneling is subcutaneous if to distal ulnar
or superficial palmar arch whereas anatomical to distal
radial artery over the anatomic snuffbox </li>
</ul></li>
</ul></li>
</ul>
</div>
<div id="vasospastic-disorders" class="section level2" number="3.4">
<h2><span class="header-section-number">3.4</span> Vasospastic Disorders</h2>
<p><strong>What is Raynaud’s and what causes it?</strong><span class="citation"><sup><a href="#ref-shuja117UpperExtremity" role="doc-biblioref">23</a>,<a href="#ref-landry141RaynaudPhenomenon2019" role="doc-biblioref">25</a></sup></span></p>
<ul>
<li>Exaggeration of normal physiologic response with episodic pallor or
cyanosis of the fingers caused by small digital artery
vasoconstriction occurring in response to cold or emotional stress.
There is an abnormality with sympathetic nervous system, resulting
in a multifactorial problem involving a combination of vascular,
neural, and humoral factors.</li>
</ul>
<p><strong>What are the subtypes of Raynaud’s phenomenon and what is the
underlying pathology?</strong></p>
<ul>
<li><p>Primary: Raynaud’s disease-idiopathic form that is a benign process
not associated with structural vascular change. Triggers include
(cold, emotional stress, caffeine) resulting in digital smooth
muscle contraction and temporary digital hypoperfusion.</p></li>
<li><p>Secondary: Fixed vascular obstruction to blood flow decreasing
threshold for cold induced vasospasm or progress to tissue loss.
Diseases associated include mixed connective tissue disease, SLE,
and rheumatoid arthritis, and scleroderma (accounts for 80-90% of
cases). In setting of lower digital blood pressure, symptomatic
digital ischemia or tissue loss under low stress conditions. With
cold/emotional stress, vasoconstrictive response of digital artery
smooth muscle further causes arterial closure and resultant symptoms</p></li>
</ul>
<p><strong>What are diagnostic criteria for Raynaud’s?</strong></p>
<ul>
<li><p>Clinical (Progression of ischemia with white -&gt; blue -&gt; red finger
discoloration. Episodes can be self-limited and may last from less
than a minute, but generally not longer than 10-20 minutes </p></li>
<li><p>Qualitative testing for severity of cold sensitivity in Raynaud’s
syndrome can be useful. Most basic test is cold sensitivity and
recovery after ice water immersion. &gt;10 minutes return to baseline
pressure concerning for Raynaud’s</p></li>
<li><p>Segmental pressures with finger systolic blood pressure can
differentiate purely vasospastic vs occlusive disease. Difference of
more than 15 mm Hg between fingers or absolute finger pressure &lt;70
mm Hg may indicate occlusive disease </p></li>
<li><p>Serologic evaluation (ANA/RF)</p></li>
</ul>
<p><strong>What are appropriate treatments for Raynaud’s phenomenon?</strong></p>
<ol style="list-style-type: decimal">
<li><p>Medical-cold/tobacco avoidance. Calcium channel blocker (nifedipine)
has been the most effective and losartan has also been beneficial.
Fluoxetine (SSRI). Other drugs include alpha blocker, sildenafil,
reserpine, cilostazol, captopril. NOT GOOD OUTCOMES IN PATIENTS WITH
ARTERIAL OBSTRUCTION </p></li>
<li><p>Surgical-thoracic sympathectomy (used for treatment of digital
artery vasospasm/digital ischemic ulceration). For vasospasm,
thoracic sympathetcomy is initially successful, but symptoms return
generally within 3-6 months. </p></li>
<li><p>Immunosuppression/immunomodulation for connective tissue disorders
associated with secondary Raynaud phenomenon</p></li>
</ol>
<div id="ergotism" class="section level3" number="3.4.1">
<h3><span class="header-section-number">3.4.1</span> <strong>Ergotism</strong></h3>
<p><strong>What is Ergotism?</strong><span class="citation"><sup><a href="#ref-jamescstanleyCurrentTherapyVascular2014" role="doc-biblioref">26</a></sup></span></p>
<ul>
<li><p>Etiology: Ergot is a parasitic fungal disease that has a particular
prevalence for infecting rye plants and ergot alkaloids have been
linked to epidemic poisonings that manifested as ergotism from
consumption of rye </p></li>
<li><p>Modern day is rare</p></li>
</ul>
<p><strong>What causes Ergotism and how do patients present?</strong></p>
<ul>
<li><p>Ergotamine is chemically like endogenous catecholamines/indolamines
and when applied clinically, it behaves as an agonist to
alpha-adrenergic, sertoninergic, and dopaminergic receptors. Despite
limited bioavailability, vasocontrictive effects have been reported
to last for 24 hours or longer </p></li>
<li><p>Gangrenous-mild limb pain followed by burning pain/shooting and </p></li>
<li><p>Convulsive-heaviness in limbs and head associated with diarrhea.
Could result in tonic-clonic spasms </p></li>
</ul>
<p><strong>How can you diagnose Ergotism and what is the process for treating
this disease?</strong></p>
<p>Upper extremity ischemia (i.e. digital ulceration) in the setting of
ergot alkaloid use (typically for migraines) </p>
<p>Treatment: </p>
<ul>
<li><p>Volume expansion and IV heparin as anticoagulation </p></li>
<li><p>IV infusion of nitroprusside, nitroglycerin, ilioprost or
combination</p></li>
<li><p>Infusion of Ca 2+ channel blockers </p></li>
<li><p>Surgical: for thrombosis, consider thrombolysis </p></li>
</ul>
</div>
<div id="buergers-disease" class="section level3" number="3.4.2">
<h3><span class="header-section-number">3.4.2</span> <strong>Buerger’s Disease</strong></h3>
<p><strong>How is Buerger’s disease categorized?</strong><span class="citation"><sup><a href="#ref-jacklcronenwettVascularDecisionMaking2020" role="doc-biblioref">24</a></sup></span></p>
<ul>
<li>Non-atherosclerotic, segmental, inflammatory disease of small/medium
sized arteries in distal extremities of tobacco users distinct from
either atherosclerosis of immune arteritis</li>
</ul>
<p><strong>What clinical criteria can help diagnose Buerger’s?</strong></p>
<ul>
<li>Smoking history, onset before 50 years, infrapopliteal arterial
occlusions, upper limb involvement, absence of atherosclerotic risk
factors besides smoking</li>
</ul>
<p><strong>What is important about diagnosing Buerger’s</strong></p>
<ul>
<li><p>Typically a diagnosis of exclusion</p></li>
<li><p>Must rule out proximal embolic source, trauma, local lesions (eg pop
entrapment or cystic adventitial disease), autoimmune disease,
hypercoagulable status, atherosclerosis</p></li>
</ul>
<p><strong>What physical exam and non-invasive/invasive imaging findings of
Buerger’s?</strong></p>
<ul>
<li><p>Distal, but not proximal arterial disease (palpable
brachial/popliteal but absent/reduced at ankle or wrist)</p></li>
<li><p>DBI&lt;0.6 and flat/reduced digital waveforms</p></li>
<li><p>CTA/MRA/DSA-characteristic corkscrew collateral</p></li>
</ul>
<p><strong>What is the mainstay treatment in Buerger’s disease?</strong></p>
<ol style="list-style-type: decimal">
<li><p>Smoking cessation! Only treatment to improve symptoms and reduce
amputation risk if achieved before onset of gangrene or tissue loss.
Important to remember following treatments will likely fail without
smoking cessation. </p></li>
<li><p>If smoking cessation does not improve, medical management with
antiplatelet agents, immunomodulators, vasodilators, anticoagulants </p></li>
<li><p>Endovascular-distal small vessel intervention</p></li>
<li><p>Surgical-upper extremity autogenous vein bypass-limited success due
to poor outflow </p></li>
<li><p>Sometimes can consider upper extremity sympathectomy, but unproven
benefit </p></li>
<li><p>Amputation-reported in 30-40% who are followed longer than 5 years </p></li>
</ol>
</div>
<div id="large-artery-vasculitis" class="section level3" number="3.4.3">
<h3><span class="header-section-number">3.4.3</span> <strong>Large Artery Vasculitis</strong></h3>
<p><strong>What are common characteristics for patients who are suspected to have
a large vessel vasculitis?</strong><span class="citation"><sup><a href="#ref-shanmugam137VasculitisOther2019" role="doc-biblioref">27</a></sup></span></p>
<ul>
<li><p>Affect aorta and major branches </p></li>
<li><p>Present with non-specific heterogenous symptoms making the diagnosis
challenging. Most commonly, they present with systemic or
constitutional symptoms (fatigue, fever, weight loss, arthralgias)</p></li>
<li><p>Frequently, diagnosis made with presence of constitutional symptoms,
elevated inflammatory markers, and dedicated imaging (MRA, CTA, DUS,
or PET)</p></li>
</ul>
<p><strong>How can you differentiate takayasu arteritis vs giant cell
arteritis?</strong></p>
<ol style="list-style-type: decimal">
<li><p>Takayasu arteritis </p>
<ol style="list-style-type: decimal">
<li><p>Aorta and primary </p></li>
<li><p>Young patients &lt;20 years and female in 80-90% of cases, Asian
populations</p></li>
<li><p>Criteria (ACR)</p>
<ol style="list-style-type: decimal">
<li><p>Onset &lt;40 years</p></li>
<li><p>Claudication of an extremity </p></li>
<li><p>Decreased brachial pulse </p></li>
<li><p>&gt;10 mmHg SBP between arms</p></li>
<li><p>Bruit over subclavian arteries or aorta</p></li>
<li><p>Arteriographic evidence of narrowing/occlusion in
aorta/primary branches/or large upper/lower extremity
arteries</p></li>
</ol></li>
</ol></li>
<li><p>Giant cell arteritis </p>
<ol style="list-style-type: decimal">
<li><p>Aorta and main branches, but pre-dilection for carotid artery
branches</p></li>
<li><p>Diagnosis: </p>
<ol style="list-style-type: decimal">
<li><p>Age at disease onset &gt; 50 years </p></li>
<li><p>New headache</p></li>
<li><p>Temporal artery abnormality </p></li>
<li><p>Elevated ESR (&gt;50) </p></li>
<li><p>Abnormal artery biopsy (gold standard test)</p></li>
</ol></li>
<li><p>Other symptoms include jaw pain with mastication or visual
changes</p></li>
<li><p>Associated with Polymyalgia rheumatic, characterized by morning
stiffness in shoulders/hips occurring in 40-50% of patients </p></li>
<li><p>Arteriography/MRA/CTA/PET may be used to assess large vessel
involvement</p></li>
</ol></li>
</ol>
<p><strong>How should patients be monitored with active large artery
vasculitis?</strong></p>
<ul>
<li><p>Lab data tracked at least monthly for 6 months with close follow-up
to ensure appropriate response to medical treatment and enable
physicians to assess for adverse effects of medical treatment</p></li>
<li><p>Repeat tests after remission reached and imaging choice to evaluate
large vessels (DUS/CTA/MRA)</p></li>
</ul>
<p><strong>What is the medical treatment for GCA and when do you consider
surgical treatment?</strong></p>
<ul>
<li><p>Medical-steroid therapy. In as many as 50% of patients who have a
large vessel vasculitis refractory to glucocorticoid therapy alone,
patients will trial immunomodulators or cytotoxic truxs (ie
methotrexate, azathioprine, mycophenolate, tocilizumab, or
leflunomide) </p></li>
<li><p>Intervention-once remission, treatment of symptomatic arterial
lesions should be considered and as many as 50-70% with large vessel
vasculitis will require intervention. </p>
<ul>
<li><p>Endovascular-angioplasty/stent/stent graft for large vessel
vasculitis have all been described, however higher restenosis in
endovascular compared to open treatment</p></li>
<li><p>Open Surgery (gold standard)-lesions are long, fibrotic and
therefore less amenable to endovascular treatment. Bypass grafts
from aorta-CCA are the most common (CEA should be avoid due to
pathology involved)</p>
<ul>
<li><p>Upper extremity bypass with autogenous vein to the brachial
artery</p></li>
<li><p>Aortic aneurysms should be managed with open surgery </p></li>
</ul></li>
</ul></li>
</ul>
</div>
</div>
<div id="aneurysmal-disease" class="section level2" number="3.5">
<h2><span class="header-section-number">3.5</span> Aneurysmal Disease</h2>
<p><strong>How are subclavian aneurysms caused and how can they present?</strong><span class="citation"><sup><a href="#ref-baig84UpperExtremity2019" role="doc-biblioref">28</a></sup></span></p>
<p>Etiology/Pathology:</p>
<ul>
<li><p>Degenerative (atherosclerotic or due to aberrant right subclavian
with degenerative changes in proximal subclavian known as “Kommerell
diverticulum”)</p></li>
<li><p>Traumatic (blunt, penetrating, iatrogenic with attempted catheter
placement) </p></li>
<li><p>Thoracic outlet obstruction</p></li>
</ul>
<p>Presentation</p>
<ul>
<li>Exam-pulsatile supraclavicular mass or bruit, absent/diminished
pulses, signs of microembolization (“blue finger”)</li>
<li>Most discovered incidentally, however referred chest, neck, shoulder
pain, upper extremity ischemia due to thromboembolic phenomenon,
brachial plexus compression, hoarseness from right recurrent
laryngeal nerve compression</li>
<li>Dysphagia from esophageal compression in aberrant right subclavian
artery</li>
</ul>
<p><strong>What are diagnostic studies and treatment modalities for subclavian
aneurysms?</strong></p>
<ul>
<li><p>CXR-mediastinal mass may suggest neoplasm</p></li>
<li><p>MRA/CTA important to delineate extent of aneurysm and proximity to
ipsilateral vertebral artery </p></li>
</ul>
<p>Treatment: </p>
<ul>
<li><p>Open Repair-resection/endoaneurysmorrhaphy with end to end (small
aneurysms) or interposition prosthetic graft </p>
<ul>
<li><p>Proximal-median sternotomy with supraclavicular fossa extension
for adequate proximal control for right side, however
supraclavicular with left anterolateral thoracotomy for left
subclavian aneurysm </p></li>
<li><p>Mid-Distal-supraclavicular/infraclavicular generally adequate
for control where again resection of the clavicle may be needed </p></li>
</ul></li>
<li><p>Endovascular Repair-transbrachial/transfemoral approach with covered
stent </p>
<ul>
<li>Must consider vertebral artery origin. Can cover vertebral
artery if contralateral vertebral artery is patent and of
adequate size, however posterior circulation stroke may occur
when the contralateral vertebral artery is highly stenotic,
hypoplastic or occluded.</li>
</ul></li>
<li><p>Hybrid Repair-embolization/coils of proximal subclavian artery
combined with subclavian transposition or carotid-subclavian bypass</p></li>
<li><p>For aberrant subclavian artery aneurysm, resection or exclusion of
the aneurysmal artery with vascular reconstruction of the subclavian
artery is recommended. Especially in the setting of dysphagia
lusoria, subclavian artery reconstructed by interposition graft
where proximal anastomosis is on ascending aorta. Alternatively,
left posterolateral thoracotomy for proximal aneurysm resection and
right supraclavicular incision for reconstruction of subclavian
artery by end to side to the right CCA has been reported.</p></li>
</ul>
<p><strong>How are axillary aneurysms caused and how can they present?</strong></p>
<p>Etiology/Pathology: </p>
<ul>
<li><p>Blunt/penetrating trauma</p></li>
<li><p>Congenital (infrequently reported)</p></li>
<li><p>Post-traumatic axillary aneurysms (repeated abduction/external
rotation downward toward humeral head in baseball pitchers) </p></li>
</ul>
<p>Presentation: </p>
<ul>
<li>Exam-pulsatile supraclavicular mass or bruit, absent/diminished
pulses, signs of microembolization (“blue finger”)</li>
</ul>
<p><strong>What are diagnostic studies and treatment modalities for axillary
aneurysms?</strong></p>
<p>Diagnosis: </p>
<ul>
<li><p>Ultrasound</p></li>
<li><p>CTA/MRA of upper extremity</p></li>
</ul>
<p>Treatment: </p>
<ul>
<li><p>Open Repair-resection with interposition vein grafting or prosthetic
if inadequate vein is present. </p></li>
<li><p>Endovascular repair-covered stent graft can be placed with
occasional embolization with micro coils to isolate sac and prevent
retrograde endoleaks</p></li>
</ul>
<p><strong>How are brachial aneurysms caused and how can they present?</strong></p>
<p>Etiology/Pathology: </p>
<ul>
<li><p>False aneurysms secondary to repetitive trauma</p></li>
<li><p>Iatrogenic complications </p></li>
<li><p>IV drug abuse (infected pseudoaneurysms in antecubital fossa) </p></li>
<li><p>Connective tissue disorders (ex. type IV Ehlers danlos)</p></li>
</ul>
<p>Presentation: </p>
<ul>
<li><p>Exam: pulsatile mass </p></li>
<li><p>Local pain or symptoms of median nerve compressions</p></li>
<li><p>Hand/digital ischemia from thrombosis/distal embolization</p></li>
</ul>
<p><strong>What are diagnostic studies and treatment modalities for brachial
aneurysms?</strong></p>
<p>Diagnosis: </p>
<ul>
<li><p>Duplex Ultrasound</p></li>
<li><p>CTA/MRA of upper extremity may be needed to delineate extent of
aneurysm </p></li>
</ul>
<p>Treatment: </p>
<ul>
<li><p>Open Repair (preferred)-resection with patch or interposition vein
grafting  </p></li>
<li><p>Endovascular repair-rare and generally in a traumatic setting</p></li>
<li><p>Iatrogenic injuries-due to access and nonoperative treatment for
small/asymptomatic pseudoaneurysms that are likely to thrombose
spontaneously. Direct suture repair with evacuation of hematoma is
possible. Thrombin injection is less favorable due to location and
short neck. </p></li>
</ul>
</div>
<div id="occupational-vascular-disease" class="section level2" number="3.6">
<h2><span class="header-section-number">3.6</span> Occupational Vascular Disease</h2>
<p><strong>There are some occupational vascular disorders than contribute to
vascular disease in the upper extremity. Hand arm vibration syndrome and
hypothenar hammer are of particular importance. Can you talk to us about
the key information from these syndromes?</strong><span class="citation"><sup><a href="#ref-eskandari185ConditionsArising2020" role="doc-biblioref">29</a></sup></span></p>
<div id="hand-arm-vibration-syndrome" class="section level3" number="3.6.1">
<h3><span class="header-section-number">3.6.1</span> Hand-Arm Vibration Syndrome </h3>
<p>Etiology:</p>
<ul>
<li><p>Vibrating handheld machines (eg pneumatic hammers and drills,
grinders, and chain saws) </p></li>
<li><p>Linear relationship between exposure over years and onset of this
syndrome </p></li>
<li><p>Exact mechanism unknown, but thought that endothelial damage with
sympathetic hyperactivity -&gt; finger blanching attack </p></li>
</ul>
<p>Presentation:</p>
<ul>
<li><p>Various stages seen where early results in slight tingling/numbness
and lateral, the tips of one or more fingers experience attacks of
blanching that is usually precipitated by cold </p></li>
<li><p>Blanching typically lasts 1 hour and terminates with reactive
hyperemia, but prolonged exposure can cause bluish black cyanosis of
fingers </p></li>
</ul>
<p>Diagnosis </p>
<ul>
<li><p>Detailed history with use of vibrating tools/symptoms of Raynaud
phenomenon </p></li>
<li><p>Objectively: cold induced ischemia with recording time until digital
temperature recovers</p></li>
<li><p>Digital occlusion with noninvasive digit pressures or duplex
scanning</p></li>
</ul>
<p>Treatment</p>
<ul>
<li><p>Avoidance of vibratory tools</p></li>
<li><p>Nifedipine (Ca2+ channel blocker) in advanced cases </p></li>
<li><p>IV prostanoid (ie prostacyclin) for digital gangrene </p></li>
<li><p>Surgery-cervical sympathetectomy or digital sympathectomy rarely
needed<br />
</p></li>
</ul>
</div>
<div id="hypothenar-hammer-syndrome" class="section level3" number="3.6.2">
<h3><span class="header-section-number">3.6.2</span> Hypothenar hammer syndrome</h3>
<p>Etiology: </p>
<ul>
<li><p>Repetitive use of palm of hand in activities that involve pushing,
pounding, twisting</p></li>
<li><p>Name comes from reports of mechanics, factory workers, carpenters or
laborers who habitually use there hands as a hammer are ad risk for
disease </p></li>
<li><p>Repetitive trauma leads to thrombotic occlusion, aneurysm formation
or both</p></li>
</ul>
<p>Presentation: </p>
<ul>
<li><p>Asymmetrical distribution involving dominant upper extremity where
cyanosis and pallor can occur and digits affected are ulnar
distribution in nature </p></li>
<li><p>Cool/mottled digits or severe cases with ischemic ulcers</p></li>
</ul>
<p>Diagnosis: </p>
<ul>
<li><p>Duplex ultrasound </p></li>
<li><p>CTA or MRA </p></li>
<li><p>Arteriography (gold standard) with corkscrew pattern typically in
affected vessels</p></li>
</ul>
<p>Treatment </p>
<ul>
<li><p>Conservative-smoking cessation/hand protection/cold avoidance </p></li>
<li><p>Medical-calcium channel blockers/antiplatelet</p></li>
<li><p>Surgical (severe digital ischemia/aneurysm)-ligation if adequate
collateral or interposition vein graft</p></li>
</ul>
</div>
<div id="environmental-exposures" class="section level3" number="3.6.3">
<h3><span class="header-section-number">3.6.3</span> Environmental Exposures</h3>
<p><strong>Exposure to what environmental agents can result in upper extremity
ischemia?</strong></p>
<p>Acrosteolysis</p>
<ul>
<li><p>Exposure to polyvinyl chloride can result in ischemic hand symptoms
similar to those of Raynaud syndrome </p></li>
<li><p>Angiography-damage to digital arteries with multiple
stenosis/occlusions or hyper vascularity adjacent to areas of bone
resorption </p></li>
<li><p>Treatment-supportive</p></li>
</ul>
<p>Electrical burns</p>
<ul>
<li><p>&lt;1000 V cause injuries limited to immediate skin/soft tissue,
however &gt;1000 V cause damage from entry to exit point </p></li>
<li><p>Results in arterial necrosis with thrombus or bleeding and gangrene
of digits develop </p></li>
<li><p>Initially can be occlusion/thrombosis or spasm, however later damage
can cause aneurysmal degeneration </p></li>
<li><p>Treatment-dependent on soft tissue/bone injuries as well. Can have
reconstruction with free flap due to local vascular damage or
occlusion of major artery requiring bypass grafting</p></li>
</ul>
<p>Extreme thermal injuries</p>
<ul>
<li><p>Workers at risk with chronic exposure to cold (slaughterhouse,
canning factory, and fisheries)</p></li>
<li><p>Raynaud syndrome symptoms due to vasomotor disturbances in the hands
when exposed to extreme chronic thermal trauma</p></li>
<li><p>Treatment-Supportive </p></li>
</ul>
</div>
<div id="sports-medicine" class="section level3" number="3.6.4">
<h3><span class="header-section-number">3.6.4</span> Sports Medicine</h3>
<p><strong>How can athletes specifically be affected by upper extremity
ischemia?</strong></p>
<p>Overview</p>
<ul>
<li>Athletes who engage in strenuous or exaggerated hand/shoulder
activity may be susceptible to upper extremity ischemia from
arterial injury manifested by Raynaud syndrome, symptoms of sudden
arterial occlusion or digital embolization</li>
</ul>
</div>
</div>
<div id="compression-syndromes" class="section level2" number="3.7">
<h2><span class="header-section-number">3.7</span> Compression Syndromes</h2>
<p><strong>The</strong> <strong>main syndromes are quadrilateral space syndrome and humeral
compression of the axillary artery. What important information here do
our listeners need to know?</strong></p>
<div id="quadrilateral-space-syndrome" class="section level3" number="3.7.1">
<h3><span class="header-section-number">3.7.1</span> Quadrilateral space syndrome</h3>
<p>Anatomy:</p>
<ul>
<li><p>Bordered by teres minor superiorly, humeral shaft laterally, and
teres major inferiorly, and long head of triceps muscle medially</p></li>
<li><p>Posterior humeral circumflex artery and axillary nerve in space</p></li>
</ul>
<p>Pathophysiology</p>
<ul>
<li><p>Compression of posterior humeral circumflex occurs with
abduction/external rotation </p></li>
<li><p>Typically seen with chronic overhand motion athletes
(pitchers/volleyball players)</p></li>
<li><p>Vascular-repetitive mechanical trauma to posterior circumflex
humeral artery </p></li>
<li><p>Neurogenic-fixed structural impaction of quadrilateral space by
fibrous bands or space-occupying lesions</p></li>
</ul>
<p>Presentation</p>
<ul>
<li>Muscle atrophy, paresthesias, poorly localized shoulder pain and
pain in quadrilateral space</li>
</ul>
<p>Treatment</p>
<ul>
<li><p>Medical: Oral anti-inflammatory medications, PT, limitation of
activities</p></li>
<li><p>Surgery: decompression with neurolysis/excision of fibrous bands or
other space occupying lesions </p></li>
</ul>
</div>
<div id="humeral-head-compression-of-axillary-artery" class="section level3" number="3.7.2">
<h3><span class="header-section-number">3.7.2</span> Humeral head compression of axillary artery</h3>
<p>Anatomy:</p>
<ul>
<li>3rd portion of axillary artery compressed by head of humerus</li>
</ul>
<p>Etiology/Pathophysiology:</p>
<ul>
<li>Arm is abducted and externally rotated with downward compression of
humeral head to axillary artery</li>
</ul>
<p>Presentation:</p>
<ul>
<li>Arm fatigue, loss of pitch velocity, finger numbness, Raynaud,
cutaneous embolization</li>
</ul>
<p>Diagnosis:</p>
<ul>
<li><p>Provocative maneuvers with impedance of flow through axillary artery
on ultrasonography</p></li>
<li><p>Arteriography with rest and provocative position</p></li>
</ul>
<p>Treatment:</p>
<ul>
<li><p>Supportive with avoidance of throwing motion</p></li>
<li><p>Surgical-saphenous vein patch for no improvement or structural
injury may require resection with saphenous vein bypass anatomically
or extra-anatomic tunneling above pec minor</p></li>
</ul>
</div>
<div id="thoracic-outlet-compression" class="section level3" number="3.7.3">
<h3><span class="header-section-number">3.7.3</span> Thoracic Outlet Compression</h3>
<p>Covered in detail here: <a href="thoracic-outlet-syndrome.html#thoracic-outlet-syndrome">4</a></p>
</div>
</div>
<div id="vascular-trauma-upper-extremity" class="section level2" number="3.8">
<h2><span class="header-section-number">3.8</span> Vascular Trauma-Upper Extremity</h2>
<p><strong>This is discussed in detail here:</strong> <a href="vascular-trauma.html#vascular-trauma">11</a>, <strong>so we
will go over some important specifics for upper extremity vascular
injury.</strong><span class="citation"><sup><a href="#ref-kauvar184VascularTrauma2020" role="doc-biblioref">30</a></sup></span></p>
<p><strong>What is the mechanism and management of upper extremity axillary
artery trauma?</strong></p>
<p>Mechanism and Pattern</p>
<ul>
<li>Predominantly in penetrating trauma with equal incidence in
proximal/middle/distal divisions and brachial plexus injury
in &gt;1/3rd of arterial injury</li>
</ul>
<p>Diagnostic Considerations</p>
<ul>
<li><p>Physical exam with deficiencies in upper extremity pulses/ischemic
changes, but may not be present given collateral flow from axillary
artery to upper extremity </p></li>
<li><p>High index of suspicion with location of injury proximity to course
of axillary artery</p></li>
<li><p>Upper extremity Doppler or CTA if patient is stable for diagnosis</p></li>
</ul>
<p>Surgical Considerations </p>
<ul>
<li><p>Primary repair or treated with interposition graft </p></li>
<li><p>If hemodynamically stable, can consider covered stent based on
location to thoracic outlet via femoral/brachial approach</p></li>
</ul>
<p><strong>What is the mechanism and management of upper extremity brachial
artery trauma?</strong></p>
<p>Mechanism and Pattern</p>
<ul>
<li><p>Frequently associated with humerus fractures/elbow dislocation</p></li>
<li><p>Penetrating trauma</p></li>
</ul>
<p>Diagnostic Considerations</p>
<ul>
<li><p>Pulse deficit in majority (&gt;75% of cases)</p></li>
<li><p>Upper extremity Doppler of CTA</p></li>
</ul>
<p>Surgical Considerations </p>
<ul>
<li>Given course, can be extensively mobilized and repaired in
end-to-end fashion in 50% of cases. Otherwise, treatment with an
interposition graft</li>
</ul>
<p><strong>What is the mechanism and management of upper extremity radial/ulnar
artery trauma?</strong></p>
<p>Mechanism and Pattern</p>
<ul>
<li>Associated with significant soft tissue pattern</li>
</ul>
<p>Diagnostic Considerations</p>
<ul>
<li><p>Pulse deficit in &gt;80% of patients </p></li>
<li><p>Doppler based Allen test-confirm radial/ulnar contribution to palmar
arch</p></li>
</ul>
<p>Surgical Considerations </p>
<ul>
<li><p>If Allen test reveals a patent palmar arch, the injured artery can
be ligated </p></li>
<li><p>If palmar arch is not patent in the absence of contribution of the
injured artery, it should be repaired</p></li>
<li><p>If both are damaged, preference to ulnar artery as dominant
contribution to hand </p></li>
<li><p>Generally, repair can be done in an end to end fashion given
mobility of the vessel</p></li>
</ul>
</div>
<div id="operationsprocedures" class="section level2" number="3.9">
<h2><span class="header-section-number">3.9</span> Operations/Procedures</h2>
<p><strong>What are some indications for carotid-subclavian bypass?</strong></p>
<ol style="list-style-type: decimal">
<li><p>Atherosclerosis </p></li>
<li><p>Staged revascularization prior to TEVAR for aneurysmal disease
requiring coverage of the LSA</p></li>
</ol>
<p><strong>How does the exposure differentiate in transposition vs bypass?</strong></p>
<p>Exposure (Transposition vs Bypass)</p>
<ul>
<li><p>Arterial transposition via a short, transverse cervical incision
above the clavicle between two heads of SCM (bypass is lateral to
entire SCM)</p></li>
<li><p>Sub-platysmal flaps created and avoid EJ vein damage</p></li>
<li><p>Omohypoid divided between heads of SCM and IJ mobilized laterally
(bypass IJ is mobilized medially to expose CCA and care must be
taken to avoid phrenic nerve in more lateral approach)</p></li>
<li><p>CCA is reflected medially with vagus nerve </p></li>
<li><p>On the left side, the thoracic duct is identifiable and divided
followed by dividing the vertebral vein</p></li>
<li><p>Subclavian artery and proximal branches identified (anterior scalene
is in lateral dissection)</p></li>
</ul>
<p><strong>What are some common complications after carotid subclavian bypass in
order of highest to lowest incidence?</strong></p>
<p>Complications<span class="citation"><sup><a href="#ref-voigtOutcomesCarotidsubclavianBypass2019" role="doc-biblioref">31</a></sup></span></p>
<ol style="list-style-type: decimal">
<li><p>Phrenic nerve palsy  </p></li>
<li><p>Recurrent laryngeal palsy  </p></li>
<li><p>Lymphatic leak  </p></li>
<li><p>Neck hematoma  </p></li>
</ol>
<p><strong>When carotid-subclavian bypass compared to transposition?</strong>  </p>
<ol style="list-style-type: decimal">
<li><p>Vertebral artery takes origin from the subclavian artery in a very
proximal position, then Bypass</p></li>
<li><p>For coronary-subclavian steal with patent internal mammary artery to
coronary artery bypass graft, then Bypass (a carotid-subclavian
transposition requires a more proximal clamp with occlusion of
inline antegrade flow to the coronary bypass during the procedure)</p></li>
</ol>

</div>
</div>
<h3>References</h3>
<div id="refs" class="references csl-bib-body">
<div id="ref-illig57UpperExtremity" class="csl-entry">
<div class="csl-left-margin">21. </div><div class="csl-right-inline">Illig KA. 57. <span>Upper Extremity Vascular Exposure</span>. In p. 12. </div>
</div>
<div id="ref-garygwindAnatomicExposuresVascular2013" class="csl-entry">
<div class="csl-left-margin">22. </div><div class="csl-right-inline">Gary G Wind, R. James Valentine. Anatomic exposures in vascular surgery. <span>Lippincott Williams &amp; Wilkins</span>; 2013. </div>
</div>
<div id="ref-shuja117UpperExtremity" class="csl-entry">
<div class="csl-left-margin">23. </div><div class="csl-right-inline">Shuja F. 117. <span>Upper Extremity Arterial Disease</span>: <span>Epidemiology</span>, <span>Etiology</span>, and <span>Diagnostic Evaluation</span>. In p. 11. </div>
</div>
<div id="ref-jacklcronenwettVascularDecisionMaking2020" class="csl-entry">
<div class="csl-left-margin">24. </div><div class="csl-right-inline">Jack L Cronenwett, Alik Farber, Erica L. Mitchell. Vascular <span>Decision Making</span>: <span>Medical</span>, <span>Endovascular</span>, <span>Surgical</span>. <span>Wolters Kluwer</span>; 2020. </div>
</div>
<div id="ref-landry141RaynaudPhenomenon2019" class="csl-entry">
<div class="csl-left-margin">25. </div><div class="csl-right-inline">Landry GJ. 141. <span>Raynaud Phenomenon</span>. In: Rutherford <span>Vascular Surgery</span> and <span>Endovascular Therapy</span>. 2019. p. 15. </div>
</div>
<div id="ref-jamescstanleyCurrentTherapyVascular2014" class="csl-entry">
<div class="csl-left-margin">26. </div><div class="csl-right-inline">Stanley JC, Veith F, Wakefield TW. Current <span>Therapy</span> in <span>Vascular</span> and <span>Endovascular Surgery</span>. <span>Elsevier Health Sciences</span>; 2014. </div>
</div>
<div id="ref-shanmugam137VasculitisOther2019" class="csl-entry">
<div class="csl-left-margin">27. </div><div class="csl-right-inline">Shanmugam VK. 137. <span>Vasculitis</span> and <span>Other Uncommon Arteriopathies</span>. In: Rutherford’s <span>Vascular Surgery</span> and <span>Endovascular Therapy</span>. 2019. p. 16. </div>
</div>
<div id="ref-baig84UpperExtremity2019" class="csl-entry">
<div class="csl-left-margin">28. </div><div class="csl-right-inline">Baig m shadman, Timaran CH. 84. <span>Upper</span> extremity aneurysms. In: Rutherford’s <span>Vascular Surgery</span> and <span>Endovascular Therapy</span>. <span>Elsevier Inc.</span>; 2019. p. 179–80. </div>
</div>
<div id="ref-eskandari185ConditionsArising2020" class="csl-entry">
<div class="csl-left-margin">29. </div><div class="csl-right-inline">Eskandari MK, Morgan CE. 185: <span>Conditions Arising From Repetitive Trauma</span> and <span>Occupational Vascular Problems</span>. Rutherford’s Vascular Surgery and Endovascular Therapy, 2-Volume Set. <span>Elsevier Inc.</span>; 2020. </div>
</div>
<div id="ref-kauvar184VascularTrauma2020" class="csl-entry">
<div class="csl-left-margin">30. </div><div class="csl-right-inline">Kauvar DS, Kraiss LW. 184: <span>Vascular Trauma</span>: <span>Extremity</span>. Rutherford’s Vascular Surgery and Endovascular Therapy, 2-Volume Set. <span>Elsevier Inc.</span>; 2020. </div>
</div>
<div id="ref-voigtOutcomesCarotidsubclavianBypass2019" class="csl-entry">
<div class="csl-left-margin">31. </div><div class="csl-right-inline">Voigt SL, Bishawi M, Ranney D, Yerokun B, McCann RL, Hughes GC. Outcomes of carotid-subclavian bypass performed in the setting of thoracic endovascular aortic repair. Journal of Vascular Surgery. 2019 Mar;69(3):701–9. </div>
</div>
</div>
            </section>

          </div>
        </div>
      </div>
<a href="cerebrovascular.html" class="navigation navigation-prev " aria-label="Previous page"><i class="fa fa-angle-left"></i></a>
<a href="thoracic-outlet-syndrome.html" class="navigation navigation-next " aria-label="Next page"><i class="fa fa-angle-right"></i></a>
    </div>
  </div>
<script src="libs/gitbook-2.6.7/js/app.min.js"></script>
<script src="libs/gitbook-2.6.7/js/clipboard.min.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-search.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-sharing.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-fontsettings.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-bookdown.js"></script>
<script src="libs/gitbook-2.6.7/js/jquery.highlight.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-clipboard.js"></script>
<script>
gitbook.require(["gitbook"], function(gitbook) {
gitbook.start({
"sharing": {
"github": false,
"facebook": true,
"twitter": true,
"linkedin": false,
"weibo": false,
"instapaper": false,
"vk": false,
"whatsapp": false,
"all": ["facebook", "twitter", "linkedin", "weibo", "instapaper"]
},
"fontsettings": {
"theme": "white",
"family": "sans",
"size": 2
},
"edit": {
"link": "https://github.com/adam-mdmph/VS-Board-Review/blob/main/02-upper-extremity.Rmd",
"text": "Edit"
},
"history": {
"link": null,
"text": null
},
"view": {
"link": null,
"text": null
},
"download": ["_main.pdf"],
"search": {
"engine": "fuse",
"options": null
},
"toc": {
"collapse": "section",
"scroll_highlight": true
}
});
});
</script>

<!-- dynamically load mathjax for compatibility with self-contained -->
<script>
  (function () {
    var script = document.createElement("script");
    script.type = "text/javascript";
    var src = "true";
    if (src === "" || src === "true") src = "https://mathjax.rstudio.com/latest/MathJax.js?config=TeX-MML-AM_CHTML";
    if (location.protocol !== "file:")
      if (/^https?:/.test(src))
        src = src.replace(/^https?:/, '');
    script.src = src;
    document.getElementsByTagName("head")[0].appendChild(script);
  })();
</script>
</body>

</html>
